{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T01:42:52Z","timestamp":1768786972115,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,1,30]],"date-time":"2015-01-30T00:00:00Z","timestamp":1422576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s00259-015-2990-0","type":"journal-article","created":{"date-parts":[[2015,1,29]],"date-time":"2015-01-29T10:49:14Z","timestamp":1422528554000},"page":"761-770","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effects of adding intravenous nicorandil to standard therapy on cardiac sympathetic nerve activity and myocyte dysfunction in patients with acute decompensated heart failure"],"prefix":"10.1007","volume":"42","author":[{"given":"Shu","family":"Kasama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuji","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Funada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Takama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norimichi","family":"Koitabashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Kurabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,30]]},"reference":[{"issue":"2","key":"2990_CR1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0002-9149(78)90162-5","volume":"41","author":"JA Thomas","year":"1978","unstructured":"Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol 1978;41(2):233\u201343.","journal-title":"Am J Cardiol"},{"issue":"13","key":"2990_CR2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJM198409273111303","volume":"311","author":"JN Cohn","year":"1984","unstructured":"Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311(13):819\u201323.","journal-title":"N Engl J Med"},{"issue":"5 Pt 1","key":"2990_CR3","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/01.CIR.78.5.1192","volume":"78","author":"EB Henderson","year":"1988","unstructured":"Henderson EB, Kahn JK, Corbett JR, Jansen DE, Pippin JJ, Kulkarni P, et al. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 1988;78(5 Pt 1):1192\u20139.","journal-title":"Circulation"},{"issue":"4","key":"2990_CR4","first-page":"471","volume":"33","author":"P Merlet","year":"1992","unstructured":"Merlet P, Valette H, Dubois-Rand\u00e9 JL, Moyse D, Duboc D, Dove P, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992;33(4):471\u20137.","journal-title":"J Nucl Med"},{"issue":"7","key":"2990_CR5","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jcmg.2013.02.007","volume":"6","author":"T Nakata","year":"2013","unstructured":"Nakata T, Nakajima K, Yamashina S, Yamada T, Momose M, Kasama S, et al. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. JACC Cardiovasc Imaging 2013;6(7):772\u201384.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"2990_CR6","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2967\/jnumed.107.047548","volume":"49","author":"S Kasama","year":"2008","unstructured":"Kasama S, Toyama T, Sumino H, Nakazawa M, Matsumoto N, Sato Y, et al. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction. J Nucl Med 2008;49(6):907\u201314.","journal-title":"J Nucl Med"},{"issue":"10","key":"2990_CR7","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/hrt.2003.023895","volume":"90","author":"Y Sato","year":"2004","unstructured":"Sato Y, Kita T, Takatsu Y, Kimura T. Biochemical markers of myocyte injury in heart failure. Heart 2004;90(10):1110\u20133.","journal-title":"Heart"},{"issue":"16","key":"2990_CR8","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1161\/01.CIR.0000145158.33801.F3","volume":"110","author":"ER Perna","year":"2004","unstructured":"Perna ER, Macin SM, Canella JP, Augier N, Stival JL, Cialzeta JR, et al. Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification. Circulation 2004;110(16):2376\u201382.","journal-title":"Circulation"},{"issue":"3","key":"2990_CR9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.CIR.103.3.369","volume":"103","author":"Y Sato","year":"2001","unstructured":"Sato Y, Yamada T, Taniguchi R, Nagai K, Makiyama T, Okada H, et al. Persistently increased serum concentrations of cardiac troponin t in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 2001;103(3):369\u201374.","journal-title":"Circulation"},{"issue":"20","key":"2990_CR10","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa0706824","volume":"358","author":"WF Peacock 4th","year":"2008","unstructured":"Peacock 4th WF, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008;358(20):2117\u201326.","journal-title":"N Engl J Med"},{"issue":"3","key":"2990_CR11","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1373\/clinchem.2006.074047","volume":"53","author":"R Sakhuja","year":"2007","unstructured":"Sakhuja R, Green S, Oestreicher EM, Sluss PM, Lee-Lewandrowski E, Lewandrowski KB, et al. Amino-terminal pro-brain natriuretic peptide, brain natriuretic peptide, and troponin T for prediction of mortality in acute heart failure. Clin Chem 2007;53(3):412\u201320.","journal-title":"Clin Chem"},{"issue":"4 Pt 1","key":"2990_CR12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0002-8703(99)70178-X","volume":"138","author":"CH Carlo Del","year":"1999","unstructured":"Del Carlo CH, O\u2019Connor CM. Cardiac troponins in congestive heart failure. Am Heart J 1999;138(4 Pt 1):646\u201353.","journal-title":"Am Heart J"},{"issue":"21","key":"2990_CR13","doi-asserted-by":"crossref","first-page":"18J","DOI":"10.1016\/0002-9149(89)90200-2","volume":"63","author":"N Taira","year":"1989","unstructured":"Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol 1989;63(21):18J\u201324.","journal-title":"Am J Cardiol"},{"issue":"9314","key":"2990_CR14","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(02)08265-X","volume":"359","author":"The IONA Study Group","year":"2002","unstructured":"The IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the Impact of Nicorandil in Angina (IONA) randomised trial. Lancet 2002;359(9314):1269\u201375.","journal-title":"Lancet"},{"issue":"9","key":"2990_CR15","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/CIRCULATIONAHA.104.530329","volume":"112","author":"H Ishii","year":"2005","unstructured":"Ishii H, Ichimiya S, Kanashiro M, Amano T, Imai K, Murohara T, et al. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation 2005;112(9):1284\u20138.","journal-title":"Circulation"},{"issue":"1","key":"2990_CR16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00259-013-2538-0","volume":"41","author":"S Kasama","year":"2014","unstructured":"Kasama S, Toyama T, Iwasaki T, Sumino H, Kumakura H, Minami K, et al. Effects of oral nicorandil therapy on sympathetic nerve activity and cardiac events in patients with chronic heart failure: subanalysis of our previous report using propensity score matching. Eur J Nucl Med Mol Imaging 2014;41(1):144\u201354.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"2990_CR17","doi-asserted-by":"crossref","first-page":"H3617","DOI":"10.1152\/ajpheart.00875.2007","volume":"293","author":"TM Lee","year":"2007","unstructured":"Lee TM, Lin MS, Chang NC. Effect of pravastatin on sympathetic reinnervation in postinfarcted rats. Am J Physiol Heart Circ Physiol 2007;293(6):H3617\u201326.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"2990_CR18","doi-asserted-by":"crossref","first-page":"e18922","DOI":"10.1371\/journal.pone.0018922","volume":"6","author":"A Sanbe","year":"2011","unstructured":"Sanbe A, Marunouchi T, Yamauchi J, Tanonaka K, Nishigori H, Tanoue A. Cardioprotective effect of nicorandil, a mitochondrial ATP-sensitive potassium channel opener, prolongs survival in HSPB5 R120G transgenic mice. PLoS One 2011;6(4):e18922.","journal-title":"PLoS One"},{"key":"2990_CR19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijcard.2011.12.080","volume":"167","author":"S Kasama","year":"2013","unstructured":"Kasama S, Toyama T, Sumino H, Kumakura H, Takayama Y, Minami K, et al. Effects of mineralocorticoid receptor antagonist spironolactone on cardiac sympathetic nerve activity and prognosis in patients with chronic heart failure. Int J Cardiol 2013;167:244\u20139.","journal-title":"Int J Cardiol"},{"issue":"5","key":"2990_CR20","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jacc.2004.11.038","volume":"45","author":"S Kasama","year":"2005","unstructured":"Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, et al. Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction. J Am Coll Cardiol 2005;45(5):661\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2990_CR21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","volume":"105","author":"MD Cerqueira","year":"2002","unstructured":"Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105(4):539\u201342.","journal-title":"Circulation"},{"issue":"5","key":"2990_CR22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80013-6","volume":"2","author":"NB Schiller","year":"1989","unstructured":"Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2(5):358\u201367.","journal-title":"J Am Soc Echocardiogr"},{"issue":"5","key":"2990_CR23","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1253\/circj.CJ-11-1110","volume":"76","author":"S Ishihara","year":"2012","unstructured":"Ishihara S, Koga T, Kaseda S, Nyuta E, Haga Y, Fujishima S, et al. Effects of intravenous nicorandil on the mid-term prognosis of patients with acute heart failure syndrome. Circ J 2012;76(5):1169\u201376.","journal-title":"Circ J"},{"issue":"Suppl 3","key":"2990_CR24","first-page":"S93","volume":"20","author":"M Krumenacker","year":"1992","unstructured":"Krumenacker M, Roland E. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy. J Cardiovasc Pharmacol 1992;20 Suppl 3:S93\u2013102.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"2990_CR25","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/BF01856508","volume":"4","author":"F Yoneyama","year":"1990","unstructured":"Yoneyama F, Satoh K, Taira N. Nicorandil increases coronary blood flow predominantly by K-channel opening mechanism. Cardiovasc Drugs Ther 1990;4(4):1119\u201326.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"3","key":"2990_CR26","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0022-5223(96)70070-3","volume":"112","author":"JR Lopez","year":"1996","unstructured":"Lopez JR, Jahangir R, Jahangir A, Shen WK, Terzic A. Potassium channel openers prevent potassium-induced calcium loading of cardiac cells: possible implications in cardioplegia. J Thorac Cardiovasc Surg 1996;112(3):820\u201331.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"2990_CR27","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0008-6363(96)88523-3","volume":"29","author":"T Mizumura","year":"1995","unstructured":"Mizumura T, Nithipatikom K, Gross GJ. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog. Cardiovasc Res 1995;29(4):482\u20139.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"2990_CR28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0735-1097(99)00539-2","volume":"35","author":"T Matsubara","year":"2000","unstructured":"Matsubara T, Minatoguchi S, Matsuo H, Hayakawa K, Segawa T, Matsuno Y, et al. Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease. J Am Coll Cardiol 2000;35(2):345\u201351.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2990_CR29","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00259-004-1672-0","volume":"32","author":"S Kasama","year":"2005","unstructured":"Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, et al. Effects of nicorandil on cardiac sympathetic nerve activity after reperfusion therapy in patients with first anterior acute myocardial infarction. Eur J Nucl Med Mol Imaging 2005;32(3):322\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"2990_CR30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/hc0202.102119","volume":"105","author":"D Neglia","year":"2002","unstructured":"Neglia D, Michelassi C, Trivieri MG, Sambuceti G, Giorgetti A, Pratali L, et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 2002;105(2):186\u201393.","journal-title":"Circulation"},{"issue":"4","key":"2990_CR31","first-page":"349","volume":"21","author":"DM Wieland","year":"1980","unstructured":"Wieland DM, Wu J, Brown LE, Mangner TJ, Swanson DP, Beierwaltes WH. Radiolabeled adrenergic neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine. J Nucl Med 1980;21(4):349\u201353.","journal-title":"J Nucl Med"},{"issue":"7","key":"2990_CR32","first-page":"1085","volume":"38","author":"Y Takeishi","year":"1997","unstructured":"Takeishi Y, Atsumi H, Fujiwara S, Takahashi K, Tomoike H. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure. J Nucl Med 1997;38(7):1085\u20139.","journal-title":"J Nucl Med"},{"issue":"10","key":"2990_CR33","first-page":"1604","volume":"44","author":"T Toyama","year":"2003","unstructured":"Toyama T, Hoshizaki H, Seki R, Isobe N, Adachi H, Naito S, et al. Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy. J Nucl Med 2003;44(10):1604\u201311.","journal-title":"J Nucl Med"},{"issue":"4","key":"2990_CR34","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1067\/mhj.2001.112783","volume":"141","author":"J Yamazaki","year":"2001","unstructured":"Yamazaki J, Muto H, Kabano T, Yamashina S, Nanjo S, Inoue A. Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy\u2013clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography. Am Heart J 2001;141(4):645\u201352.","journal-title":"Am Heart J"},{"issue":"1","key":"2990_CR35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1124\/jpet.103.059832","volume":"309","author":"C Burgdorf","year":"2004","unstructured":"Burgdorf C, Dendorfer A, Kurz T, Sch\u00f6mig E, St\u00f6lting I, Sch\u00fctte F, et al. Role of neuronal KATP channels and extraneuronal monoamine transporter on norepinephrine overflow in a model of myocardial low flow ischemia. J Pharmacol Exp Ther 2004;309(1):42\u20138.","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"2990_CR36","doi-asserted-by":"crossref","first-page":"H1949","DOI":"10.1152\/ajpheart.00903.2008","volume":"296","author":"CS Kang","year":"2009","unstructured":"Kang CS, Chen CC, Lin CC, Chang NC, Lee TM. Effect of ATP-sensitive potassium channel agonists on sympathetic hyperinnervation in postinfarcted rat hearts. Am J Physiol Heart Circ Physiol 2009;296(6):H1949\u201359.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"22","key":"2990_CR37","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1161\/CIRCULATIONAHA.107.187397","volume":"116","author":"K Thygesen","year":"2007","unstructured":"Thygesen K, Alpert JS, White HD, Joint ESC\/ACCF\/AHA\/WHF Task Force for the Redefinition of Myocardial Infarction, Jaffe AS, Apple FS, et al. Universal definition of myocardial infarction. Circulation 2007;116(22):2634\u201353.","journal-title":"Circulation"},{"issue":"5","key":"2990_CR38","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.annemergmed.2007.09.004","volume":"51","author":"CV Pollack Jr","year":"2008","unstructured":"Pollack Jr CV, Braunwald E. 2007 update to the ACC\/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: implications for emergency department practice. Ann Emerg Med 2008;51(5):591\u2013606.","journal-title":"Ann Emerg Med"},{"issue":"3","key":"2990_CR39","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jjcc.2012.06.007","volume":"60","author":"Y Sato","year":"2012","unstructured":"Sato Y, Fujiwara H, Takatsu Y. Cardiac troponin and heart failure in the era of high-sensitivity assays. J Cardiol 2012;60(3):160\u20137.","journal-title":"J Cardiol"},{"issue":"8","key":"2990_CR40","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00259-013-2431-x","volume":"40","author":"K Nakajima","year":"2013","unstructured":"Nakajima K, Okuda K, Nystr\u00f6m K, Richter J, Minarik D, Wakabayashi H, et al. Improved quantification of small hearts for gated myocardial perfusion imaging. Eur J Nucl Med Mol Imaging 2013;40(8):1163\u201370.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"2990_CR41","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00259-008-0971-2","volume":"36","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Nakajima K, Okuda K, Kawano M, Ishikawa T, Hosoya T, et al. Standardization of the heart-to-mediastinum ratio of 123I-labelled-metaiodobenzylguanidine uptake using the dual energy window method: feasibility of correction with different camera-collimator combinations. Eur J Nucl Med Mol Imaging 2009;36(4):560\u20136.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-015-2990-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-015-2990-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-015-2990-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:06:23Z","timestamp":1558699583000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-015-2990-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,30]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["2990"],"URL":"https:\/\/doi.org\/10.1007\/s00259-015-2990-0","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,30]]}}}